Cargando…
Challenges in the Use of Targeted Therapies in Non–Small Cell Lung Cancer
Precision oncology has fundamentally changed how we diagnose and treat cancer. In recent years, there has been a significant change in the management of patients with oncogene-addicted advanced-stage non–small cell lung cancer (NSCLC). Increasing amounts of identifiable oncogene drivers have led to...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Cancer Association
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016301/ https://www.ncbi.nlm.nih.gov/pubmed/35209703 http://dx.doi.org/10.4143/crt.2022.078 |